Chris Lange

Chris Lange is an analyst for 24/7 Wall St., based in Houston. He has covered financial markets over the past five years with an emphasis on healthcare, tech, and IPOs. During this time, he has published thousands of articles with insightful analysis across these complex fields.

Lange's work has been quoted or mentioned in Forbes, The New York Times, Business Insider, USA Today, MSN, Yahoo, The Verge, Vice, The Intelligencer, Quartz, Nasdaq, The Motley Fool, Fox Business, International Business Times, The Street, Seeking Alpha, Barron’s, Benzinga, and many other major publications.

A graduate of Southwestern University in Georgetown, Texas, Lange majored in business with a particular focus on investments. He has previous experience in the banking industry and has helped start a small business.

Lastest Stories by Chris Lange

Bed Bath & Beyond reported its fiscal third quarter financial results before the markets opened on Thursday and investors were not happy.
Costco Wholesale has reported its sales results for the month of December.
Tuesday afternoon’s analyst upgrades and downgrades included Citigroup, Goldman Sachs, JPMorgan and Tesla.
Macy’s shares climbed on Wednesday after the company said it would be shuttering more stores.
Petco intends to sell 48 million shares in an initial public offering valued up to more than $930 million.
24/7 Wall St. is looking at some big analyst calls that we have seen so far on Tuesday. We have included the most recent analyst call on each stock, as well as a recent trading history and the...
Although the markets may be falling, 24/7 Wall St. is taking a look at some big analyst calls that we have seen so far on Monday.
Here's what analysts are saying about each of some hop IPOs after the quiet period has lifted.
The post-IPO quiet period for C3.ai has ended, and one analyst sees more than 50% more upside in the stock.
The SEC moved quickly and decisively earlier this week when it filed an emergency action and obtained an order imposing an asset freeze and other emergency relief against Virgil Capital and its...
The question for many investors is whether semiconductor stocks can keep up this rally and keep the markets hitting all-time highs.
Arcturus Therapeutics shares took a tumble on Tuesday after the company announced update on its COVID-19 vaccine candidate.
Analysts have raised their targets and issued some very interesting calls lately on which stocks they think will be major players in the coming year, from Apple to Walmart.
Aprea Therapeutics stock was absolutely crushed to start out the week after the company announced results from its late-stage trial evaluating the safety and efficacy of its treatment for...
Myovant shares shot up on Monday after the company announced a new collaboration with Pfizer for its tumor treatment across a couple of indications.